Literature DB >> 22392052

CXCL12 in control of neuroinflammation.

Miljana Momcilović1, Marija Mostarica-Stojković, Djordje Miljković.   

Abstract

Inflammation within the central nervous system (CNS) is strictly controlled and if possible prevented. Such a tight control is necessary due to high sensitivity of nervous tissue to mechanical and biochemical consequences of inflammation. Still, neuroinflammation is a typical feature of a chronic, inflammatory, demyelinating disease multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). It is assumed that mechanisms that should prevent activation of immune cells at the periphery, in the lymphoid tissues, and/or inflammation within the CNS are inadequately efficient in MS patients. Here, some recent data about the importance of CXCL12 for regulation of neuroinflammation and contribution of its deviant expression within the CNS to EAE and MS pathogenesis are presented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392052     DOI: 10.1007/s12026-012-8282-x

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  113 in total

1.  Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

Authors:  J L Pablos; A Amara; A Bouloc; B Santiago; A Caruz; M Galindo; T Delaunay; J L Virelizier; F Arenzana-Seisdedos
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.

Authors:  Karl Balabanian; Bernard Lagane; Simona Infantino; Ken Y C Chow; Julie Harriague; Barbara Moepps; Fernando Arenzana-Seisdedos; Marcus Thelen; Françoise Bachelerie
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

3.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

Authors:  G A Donzella; D Schols; S W Lin; J A Esté; K A Nagashima; P J Maddon; G P Allaway; T P Sakmar; G Henson; E De Clercq; J P Moore
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

4.  Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.

Authors:  Vittorio Calabrese; Giovanni Scapagnini; Agrippino Ravagna; Rita Bella; Roberta Foresti; Timothy E Bates; Anna-Maria Giuffrida Stella; Giovanni Pennisi
Journal:  J Neurosci Res       Date:  2002-11-15       Impact factor: 4.164

5.  AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

Authors:  P Matthys; S Hatse; K Vermeire; A Wuyts; G Bridger; G W Henson; E De Clercq; A Billiau; D Schols
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

6.  Evidence for the production of peroxynitrite in inflammatory CNS demyelination.

Authors:  A H Cross; P T Manning; M K Stern; T P Misko
Journal:  J Neuroimmunol       Date:  1997-12       Impact factor: 3.478

7.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.

Authors:  Zhenhua Miao; Kathryn E Luker; Bretton C Summers; Rob Berahovich; Mahaveer S Bhojani; Alnawaz Rehemtulla; Celina G Kleer; Jeffrey J Essner; Aidas Nasevicius; Gary D Luker; Maureen C Howard; Thomas J Schall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

8.  Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.

Authors:  Frederic Sierro; Christine Biben; Laura Martínez-Muñoz; Mario Mellado; Richard M Ransohoff; Meizhang Li; Blanche Woehl; Helen Leung; Joanna Groom; Marcel Batten; Richard P Harvey; Carlos Martínez-A; Charles R Mackay; Fabienne Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

Review 9.  Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.

Authors:  Hans Lassmann
Journal:  Exp Neurol       Date:  2009-10-17       Impact factor: 5.330

10.  CXCR7 functions as a scavenger for CXCL12 and CXCL11.

Authors:  Ulrike Naumann; Elisabetta Cameroni; Monika Pruenster; Harsha Mahabaleshwar; Erez Raz; Hans-Günter Zerwes; Antal Rot; Marcus Thelen
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more
  13 in total

Review 1.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

2.  The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population.

Authors:  Jerzy Mrowicki; Karolina Przybylowska-Sygut; Lukasz Dziki; Andrzej Sygut; Jan Chojnacki; Adam Dziki; Ireneusz Majsterek
Journal:  Mol Biol Rep       Date:  2014-04-01       Impact factor: 2.316

3.  Central SDF-1/CXCL12 expression and its cardiovascular and sympathetic effects: the role of angiotensin II, TNF-α, and MAP kinase signaling.

Authors:  Shun-Guang Wei; Zhi-Hua Zhang; Yang Yu; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

4.  Activation and Regulation of NLRP3 Inflammasome by Intrathecal Application of SDF-1a in a Spinal Cord Injury Model.

Authors:  Adib Zendedel; Sonja Johann; Soraya Mehrabi; Mohammad-Taghi Joghataei; Gholamreza Hassanzadeh; Markus Kipp; Cordian Beyer
Journal:  Mol Neurobiol       Date:  2015-05-14       Impact factor: 5.590

5.  Patterns and Persistence of Perioperative Plasma and Cerebrospinal Fluid Neuroinflammatory Protein Biomarkers After Elective Orthopedic Surgery Using SOMAscan.

Authors:  Simon T Dillon; Hasan H Otu; Long H Ngo; Tamara G Fong; Sarinnapha M Vasunilashorn; Zhongcong Xie; Lisa J Kunze; Kamen V Vlassakov; Ayesha Abdeen; Jeffrey K Lange; Brandon E Earp; Zara R Cooper; Eva M Schmitt; Steven E Arnold; Tammy T Hshieh; Richard N Jones; Sharon K Inouye; Edward R Marcantonio; Towia A Libermann
Journal:  Anesth Analg       Date:  2022-04-07       Impact factor: 6.627

Review 6.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

7.  Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.

Authors:  Jana Blaževski; Filip Petković; Miljana Momčilović; Reinhard Paschke; Goran N Kaluđerović; Marija Mostarica Stojković; Djordje Miljković
Journal:  Acta Pharmacol Sin       Date:  2013-02-04       Impact factor: 6.150

8.  Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells.

Authors:  Joanna Ślusarczyk; Ewa Trojan; Katarzyna Głombik; Bogusława Budziszewska; Marta Kubera; Władysław Lasoń; Katarzyna Popiołek-Barczyk; Joanna Mika; Krzysztof Wędzony; Agnieszka Basta-Kaim
Journal:  Front Cell Neurosci       Date:  2015-03-12       Impact factor: 5.505

9.  Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats.

Authors:  Suzana Stanisavljević; Jovanka Lukić; Svetlana Soković; Sanja Mihajlovic; Marija Mostarica Stojković; Djordje Miljković; Natasa Golić
Journal:  Front Microbiol       Date:  2016-12-15       Impact factor: 5.640

10.  Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.

Authors:  Kavitha Kothur; Louise Wienholt; Shekeeb S Mohammad; Esther M Tantsis; Sekhar Pillai; Philip N Britton; Cheryl A Jones; Rajeshwar R Angiti; Elizabeth H Barnes; Timothy Schlub; Sushil Bandodkar; Fabienne Brilot; Russell C Dale
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.